Knowing the difference between a medication that needs more time and one that genuinely isn’t working is one of the most important skills in psychiatric care.
Starting an antidepressant takes a particular kind of hope.
You’ve acknowledged something is wrong. You’ve made the appointment. You’ve had the conversation. And now you’re waiting, because antidepressants don’t work overnight, and everyone has told you to give it time.
So you give it time. Weeks pass. Maybe you feel a little better. Maybe you feel about the same. Maybe you feel worse. And somewhere around week four or six or eight, you start to wonder whether what you’re experiencing is the medication working, the medication failing, your situation improving, or simply the passage of time doing what it always does.
It’s a genuinely difficult thing to assess from the inside. And it matters, because staying on a medication that isn’t working means continuing to suffer while missing the opportunity to try something that might actually help. But switching too quickly means never giving anything a real chance.
Here’s a careful look at the signs that depression isn’t responding to medication, what they mean, and what the right next steps actually look like.
What response to antidepressant treatment actually means
Before getting to the signs of non-response, it helps to be clear about what response means in clinical terms.
Response is typically defined as a fifty percent or greater reduction in symptom severity from baseline. Remission is a fuller recovery, the near-complete resolution of symptoms and a return to baseline functioning. These are the targets that matter clinically, and they’re worth knowing because partial improvement, feeling somewhat better but still significantly impaired, is not the same as treatment working.
A substantial proportion of people who take antidepressants experience partial response. They feel better than they did. Sleep may have improved. The darkest moments may have lifted. But the motivation is still flat. The concentration is still poor. The capacity for pleasure still feels muted. The fog hasn’t fully cleared.
Partial improvement is valuable and worth acknowledging. It is not, however, the ceiling of what’s possible. Many people accept partial response as the best they can do when better is genuinely available.
The timeline question
The most common source of confusion about antidepressant response is the timeline — and the source of that confusion is often incomplete information at the start of treatment.
Antidepressants begin to produce some effects relatively early. Sleep often improves within the first one to two weeks. Energy and physical symptoms sometimes shift before mood does. These early changes are encouraging signs that the medication is doing something, and they matter clinically even when the mood component hasn’t yet moved.
Full antidepressant effect on mood, motivation, and the core depressive symptoms typically takes four to eight weeks at a therapeutic dose. Some patients take longer. The mechanism — neuroplasticity, changes in receptor sensitivity, downstream effects on brain circuits — unfolds over time rather than all at once.
This creates two common errors. The first is stopping too early — discontinuing a medication at two or three weeks because it hasn’t worked yet, when it may simply need more time. The second is waiting too long on a medication that has clearly plateaued at an insufficient level of benefit, on the assumption that more time will produce more improvement when the evidence suggests otherwise.
By week four to six at a therapeutic dose, there is usually enough signal to make a reasonable clinical judgment. Not necessarily a final one — but enough to assess trajectory. If there has been meaningful improvement and the trajectory is still upward, continuing is reasonable. If there has been no improvement at all, or only minimal improvement that hasn’t progressed, the case for waiting significantly longer is weaker.
Signs that depression is not responding to medication
These are the clinical signals that deserve a direct conversation with your prescriber rather than continued waiting.
No change in core symptoms after a full trial. The most straightforward sign. After four to eight weeks at a therapeutic dose, the low mood, the loss of interest in things you used to care about, the anhedonia, the emptiness — are exactly as present as they were before starting. Nothing has shifted. This is meaningful clinical information that should not be ignored.
Functioning is still significantly impaired. You’re still missing work or performing well below your capacity. Relationships are still suffering. Daily tasks still feel impossible. You’re not getting out of bed. You’re not eating. A medication that is working should eventually be producing improvement in functional capacity — how you’re actually living — not just in scores on a symptom checklist.
Sleep has normalized but nothing else has. Sleep improvement is often the earliest sign that an antidepressant is doing something. It’s encouraging when it happens. But sleep improvement that doesn’t eventually translate into improved mood, motivation, and function after adequate time may reflect a medication that’s doing one thing and not another — a meaningful partial response, not a trajectory toward remission.
You feel better briefly, then relapse. An initial lift that fades — sometimes called the antidepressant poop-out or medication tolerance — is a recognized pattern. The medication produced early improvement that wasn’t sustained. This can happen at any point in treatment and is a signal that the current approach isn’t providing stable, durable benefit.
Side effects are present but benefits aren’t. Taking on the burden of side effects — weight gain, sexual dysfunction, sedation, cognitive dulling — while the medication produces no meaningful benefit is a clear signal that the calculus has shifted. Side effects are worth tolerating when the medication is genuinely helping. They’re not worth tolerating when it isn’t.
You feel numb or emotionally flat without improvement in depression. Emotional blunting — a muted, dampened emotional range in which you can’t fully access either positive or negative feelings — is a recognized side effect of antidepressants, particularly SSRIs at higher doses. When this isn’t accompanied by improvement in the core depressive symptoms, it reflects a medication producing side effects without benefit.
You’ve had to increase the dose repeatedly without sustained improvement. Some dose titration is expected. But escalating through the full dose range of a medication without finding a level that produces durable improvement is a signal that the medication may not be the right fit — or that something else is driving the depression that the medication isn’t equipped to address.
Suicidal thoughts have returned or worsened. This is the most urgent signal. Worsening suicidal ideation, increased hopelessness, or a return of thoughts about not wanting to be alive while on antidepressant treatment is a situation that warrants immediate clinical contact — not waiting for the next scheduled appointment.
The dose question that often goes unasked
One of the most common reasons depression appears not to respond to medication is that the medication was never at a dose that could reasonably be expected to work.
This is a structural problem in how antidepressants are often prescribed. Starting doses are conservative — appropriately so, to minimize early side effects. But in busy practices with short appointment windows, doses sometimes never get titrated upward to the therapeutic range. A patient on sertraline 50mg for six months who reports that it hasn’t helped may never have tried sertraline at 150 or 200mg, which is where it’s most likely to produce antidepressant benefit.
Before concluding that a medication has failed, it’s worth confirming — with your prescriber or a second opinion — that the dose actually reached a level that’s consistent with evidence-based treatment.
The diagnosis question
A more uncomfortable but frequently important question: is the diagnosis right?
This isn’t meant to undermine the reality of what you’ve experienced. It’s a clinical observation that the most common reason depression doesn’t respond to standard treatment is that the treatment is targeting the wrong condition or an incomplete version of the right one.
Undetected bipolar disorder is the most frequent diagnostic miss. Bipolar depression, particularly the Bipolar II pattern characterized by depressive episodes and hypomanic episodes that felt like good periods rather than symptoms, is often initially diagnosed and treated as major depression. Antidepressants alone in bipolar disorder frequently fail to produce sustained benefit, and sometimes destabilize mood in ways that look like antidepressant failure when they’re actually a signal about the underlying condition.
ADHD masquerading as depression is another common pattern. Chronic ADHD produces genuine low mood, low motivation, and a depleted sense of self that looks like depression. SSRIs and SNRIs don’t treat ADHD, and treating the depression without recognizing the ADHD underneath it often produces limited results.
PTSD and complex trauma generate depressive symptoms that are downstream of trauma-related neural changes. Antidepressants can help with some of the symptom load, but without trauma-focused treatment, the core condition remains unaddressed and depression often persists.
A medical driver — thyroid dysfunction, anemia, vitamin deficiencies, sleep apnea, hormonal changes, chronic pain, or autoimmune conditions — can produce or worsen depression in ways that antidepressants don’t adequately reach. A thorough workup that identifies and treats medical contributors is sometimes what makes the difference between a medication that doesn’t work and one that does.
What non-response is telling you
Here’s the reframe worth sitting with.
An antidepressant not working is not a verdict about you. It’s not evidence that your depression is too severe to treat, that your brain is broken, or that you’ve exhausted your options. It’s clinical information — a signal that this specific mechanism, at this specific dose, addressing this particular target, is not the right match for whatever is actually driving your depression.
That information is useful. It narrows the field. It points toward questions that deserve answers: Was the trial actually adequate? Is the diagnosis complete? Are there medical contributors that haven’t been addressed? Is there an untreated co-occurring condition shaping the picture?
Treatment-resistant depression — the technical term for depression that hasn’t responded to adequate medication trials — has more treatment options than at any previous point in psychiatric history. Medication optimization, augmentation strategies, switching to different classes, addressing co-occurring conditions, psychotherapy matched to what’s actually driving the picture, and for genuinely resistant cases, advanced interventional treatments like TMS, Spravato, and ketamine therapy.
None of those options are available until the question is asked clearly — and the question is often only asked clearly once someone names that the current approach isn’t working.
What to do when you recognize these signs
Have the conversation with your prescriber directly and specifically. Not “I don’t know if this is working” — but “here are the specific symptoms that haven’t improved, and here is how my functioning is still affected.” Concrete, specific, functional information helps a prescriber assess the situation more accurately than a general sense of uncertainty.
Ask explicit questions. Has the dose actually reached the therapeutic range? Is the diagnosis still what we think it is? What would a next step look like? Is there a different class of medication worth trying? Is there a reason to add something? Should I be assessed for conditions that might be driving this?
If the conversation doesn’t feel productive — if the response is to simply wait longer or add another refill — a second opinion is entirely appropriate. Treatment-resistant depression, or what appears to be treatment-resistant depression, is exactly the situation that specialized psychiatric evaluation is built for.
And if suicidal thoughts are part of the picture, don’t wait for the next appointment. Contact your prescriber urgently, go to an emergency department, or call or text 988.
The takeaway
Depression not responding to medication is one of the most common situations in psychiatric care — and one of the most underaddressed. The path forward requires naming what’s happening directly, asking the questions that need asking, and working with a clinician willing to go deeper than another prescription refill.
The signs that a medication isn’t working are recognizable. The reasons behind non-response are often identifiable. And the options that come next — once the right questions are asked — are more numerous than most people realize at the moment they feel most stuck.
Goldstone Psychiatry & Neuromodulation Center offers specialized evaluation and treatment for depression, including cases that haven’t responded to standard medication approaches. Telepsychiatry is available throughout Texas.